Song Z - Search Results

1

Targeting KRAS mutant cancers: from druggable therapy to drug resistance.

Zhu C, Guan X, Zhang X, Luan X, Song Z, Cheng X, Zhang W, Qin JJ. Zhu C, et al. Among authors: song z. Mol Cancer. 2022 Aug 4;21(1):159. doi: 10.1186/s12943-022-01629-2. Mol Cancer. 2022. PMID: 35922812 Free PMC article. Review.

2

[Advances of molecular subtype and targeted therapy of lung cancer].

Shao L, Song Z, Zhang Y, Su D. Shao L, et al. Among authors: song z. Zhongguo Fei Ai Za Zhi. 2012 Sep;15(9):545-52. doi: 10.3779/j.issn.1009-3419.2012.09.07. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22989458 Free PMC article. Review. Chinese.

3

Patients with ROS1 rearrangement-positive non-small-cell lung cancer benefit from pemetrexed-based chemotherapy.

Song Z, Su H, Zhang Y. Song Z, et al. Cancer Med. 2016 Oct;5(10):2688-2693. doi: 10.1002/cam4.809. Epub 2016 Aug 20. Cancer Med. 2016. PMID: 27544536 Free PMC article.

4

Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma.

Song Z, Yu X, Zhang Y. Song Z, et al. Cancer Med. 2016 Oct;5(10):2694-2700. doi: 10.1002/cam4.852. Epub 2016 Aug 23. Cancer Med. 2016. PMID: 27554588 Free PMC article.

5

Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma.

Lou G, Yu X, Song Z. Lou G, et al. Among authors: song z. Clin Lung Cancer. 2017 May;18(3):e197-e201. doi: 10.1016/j.cllc.2016.11.014. Epub 2016 Dec 2. Clin Lung Cancer. 2017. PMID: 28024928

6

Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study.

Wang W, Gu X, Si J, Pu X, Wang L, Chen H, Xu C, Zhang X, Yuan H, Lou G, Shao L, Zhang G, Song Z. Wang W, et al. Among authors: song z. Genes Chromosomes Cancer. 2022 Sep;61(9):530-541. doi: 10.1002/gcc.23043. Epub 2022 Apr 23. Genes Chromosomes Cancer. 2022. PMID: 35396765

7

Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.

Xu M, Hao Y, Zhou H, Shi Z, Si J, Song Z. Xu M, et al. Among authors: song z. Med Oncol. 2023 Jun 9;40(7):198. doi: 10.1007/s12032-023-02059-w. Med Oncol. 2023. PMID: 37294384

8

[Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor].

Zheng L, Lin B, Song Z, Xie F, Hong W, Feng J, Shao L, Zhang Y. Zheng L, et al. Among authors: song z. Zhongguo Fei Ai Za Zhi. 2013 Dec;16(12):632-8. doi: 10.3779/j.issn.1009-3419.2013.12.03. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24345487 Free PMC article. Clinical Trial. Chinese.

9

Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients.

Song Z, Yu X, Zhang Y. Song Z, et al. Cancer Biol Ther. 2017 Nov 2;18(11):883-887. doi: 10.1080/15384047.2016.1235660. Epub 2016 Sep 16. Cancer Biol Ther. 2017. PMID: 27635639 Free PMC article.

10

Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma.

Song Z, Yu X, Zhang Y. Song Z, et al. Lung Cancer. 2016 Nov;101:16-21. doi: 10.1016/j.lungcan.2016.09.002. Epub 2016 Sep 9. Lung Cancer. 2016. PMID: 27794403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,959 results

Search Page

Filters